Up-Regulation of Activating Transcription Factor 3 in Human Fibroblasts Inhibits Melanoma Cell Growth and Migration Through a Paracrine Pathway is a research paper published in Frontiers in Oncology (2020). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Natural Science Foundation of China
Grant: 81572681
National Natural Science Foundation of China
Grant: 81772093
Natural Science Foundation of Shandong Province
Grant: 2019GSF108107
Natural Science Foundation of Shandong Province
Grant: ZR2019ZD36
Foundation for the National Institutes of Health
Grant: 2P01CA163222
Foundation for the National Institutes of Health
Grant: 5R01 AR043369-23
Foundation for the National Institutes of Health
Grant: 5R01AR072304
Foundation for the National Institutes of Health
Grant: 5R01CA222871
NIAMS NIH HHS
Grant: R01 AR043369
NCI NIH HHS
Grant: R01 CA222871
NCI NIH HHS
Grant: P01 CA163222
NIAMS NIH HHS
Grant: R01 AR072304
National Institutes of Health
Grant: 5R01AR043369-28
MITF from control of pigmentation to melanoma risk
National Institutes of Health
Grant: 5P01CA163222-08
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
National Institutes of Health
Grant: 5R01AR072304-04
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
National Institutes of Health
Grant: 1R01CA222871-01
A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
National Key Research and Development Program of China Stem Cell and Translational Research
FWCI
0.37
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals